Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Maytenus macrocarpa
Un grand arbre amazonien dont l'écorce est utilisée comme un anti-inflammatoire puissant et un tonique immunitaire tout au long du Pérou.
Chuchuhuasi (Maytenus macrocarpa) is a large Amazonian tree whose bark is traditionally used as a powerful anti-inflammatory and immune tonic. It is employed for arthritis, back pain, and digestive support, and contains bioactive compounds such as mayteine, maytansine, pristimerin, and friedelin. Evidence for its efficacy is primarily traditional and limited clinical studies.
The anti-inflammatory effects of Chuchuhuasi are attributed to pristimerin and friedelin, which inhibit NF-κB activation and reduce COX-2 expression, thereby decreasing pro-inflammatory cytokines. Maytansine, a potent microtubule inhibitor, contributes to analgesic and immunomodulatory actions by disrupting cellular division and signaling pathways. Additionally, the bark's compounds may modulate opioid receptors and TRPV1 channels, providing pain relief. These mechanisms collectively support its traditional use for arthritis and immune support.
Un grand arbre amazonien dont l'écorce est utilisée comme un anti-inflammatoire puissant et un tonique immunitaire tout au long du Pérou.
Chuchuhuasi (Maytenus macrocarpa) is a large Amazonian tree whose bark is traditionally used as a powerful anti-inflammatory and immune tonic. It is employed for arthritis, back pain, and digestive support, and contains bioactive compounds such as mayteine, maytansine, pristimerin, and friedelin. Evidence for its efficacy is primarily traditional and limited clinical studies.
The anti-inflammatory effects of Chuchuhuasi are attributed to pristimerin and friedelin, which inhibit NF-κB activation and reduce COX-2 expression, thereby decreasing pro-inflammatory cytokines. Maytansine, a potent microtubule inhibitor, contributes to analgesic and immunomodulatory actions by disrupting cellular division and signaling pathways. Additionally, the bark's compounds may modulate opioid receptors and TRPV1 channels, providing pain relief. These mechanisms collectively support its traditional use for arthritis and immune support.